Condition: Hematopoietic Stem Cell Transplantation · Cytomegalovirus Infections · Epstein-Barr Virus Infections · Sponsor: The First Affiliated Hospital of Soochow University
The purpose of this prospective, open-label, Single Arm, single-center study is to evaluate the cytomegalovirus and Epstein-Barr virus specific immune reestablishment for patients with hemopathy undergoingin prophylaxis for cytomegalovirus in haploid hematopoietic stem cell transplantation(haplo-HSCT) .
This description comes directly from the study's public registry record.
Feng Chen, PhD · 13584861215 · 13584861215@163.com
Depei Wu, PhD · 67781856 · drwudepei@163.com
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital of Soochow University | Suzhou, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06554197